How much does filgrastim cost (typical prices)
Costs for filgrastim vary widely by country, dose, vial/strength, and whether you use the originator product or a biosimilar. Filgrastim is sold under multiple brand and biosimilar names, so the “per dose” price can change based on which version your pharmacy stocks and what your insurer covers.
If you tell me your location (country) and the form/strength you’re using (for example, number of mcg or mg per vial/syringe), I can help you estimate a more realistic out-of-pocket range.
How biosimilars change the price
Biosimilar filgrastim products are typically priced lower than the original reference product, and many health systems prefer biosimilars when available. In practice, the lowest cost is often tied to formulary placement (which product your insurer covers) rather than the medication being “filgrastim” in general.
What affects your out-of-pocket cost the most
Your final cost usually depends on:
- Insurance coverage and formulary tier (preferred vs non-preferred)
- Whether your plan covers the exact brand/biosimilar used
- Pharmacy setting (hospital outpatient vs retail pharmacy)
- Quantity needed for your treatment schedule (number of injections)
- Any patient assistance programs, co-pay cards, or government drug programs available where you live
How many injections drive total cost
Filgrastim regimens can differ based on why it’s prescribed (for example, chemotherapy-induced neutropenia support). Total drug cost is often dominated by the number of doses you receive rather than the price of a single vial/syringe.
If you share your prescribed schedule (dose and number of days), I can estimate total medication cost more directly.
Price differences by where you buy
Prices can differ between:
- Retail pharmacies
- Specialty pharmacies
- Hospital pharmacies (often influenced by billing and reimbursement structures)
- Online/wholesale purchasing routes (which vary by legality and country)
If you’re comparing options: filgrastim vs similar drugs
People sometimes compare filgrastim to related agents (like pegfilgrastim) because dosing schedules differ. Switching can change total cost even if the per-injection drug price is higher or lower. Whether switching is reasonable depends on your clinical plan and insurer requirements.
What I need to give a concrete estimate
Reply with:
1) Your country (and state/province if relevant)
2) The exact product name (or whether it’s “filgrastim” vs a specific biosimilar)
3) The dose (mcg per injection) and how many injections/days
4) Whether you have insurance and your expected responsibility (if you know it)
With that, I can translate “filgrastim cost” into a practical per-dose and total-treatment estimate using the most likely pricing setup.
Sources
No sources were provided with your question.